Company creates U.S. subsidiary and adds Dr. Jeffrey Jeddeloh as VP of Business Development, Commercial Strategy, Dr. Stephen Macevicz as VP of IP and Dr. Christine Peponnet as VP of Technology Development. PARIS and CAMBRIDGE, Mass. – DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation of DNA Script

To read the full story...

Already a subscriber? Login now

< | >